Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 169

    1.

    In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance.

    Kopprasch S, Pietzsch J, Kuhlisch E, Fuecker K, Temelkova-Kurktschiev T, Hanefeld M, Kühne H, Julius U, Graessler J.

    Diabetes. 2002 Oct;51(10):3102-6.PMID: 12351454 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus.

    Kopprasch S, Pietzsch J, Kuhlisch E, Graessler J.

    J Clin Endocrinol Metab. 2003 Apr;88(4):1711-6.PMID: 12679462 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.

    Serin O, Konukoglu D, Firtina S, Mavis O.

    Horm Metab Res. 2007 Mar;39(3):207-11.PMID: 17373636 [PubMed - indexed for MEDLINE]Related articles

    4.

    Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.

    Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I.

    Diabetes Care. 1995 May;18(5):646-53.PMID: 8586002 [PubMed - indexed for MEDLINE]Related articles

    5.

    Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.

    Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K.

    Metabolism. 2004 Mar;53(3):297-302.PMID: 15015140 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).

    Uddin F, Miah AK.

    Bangladesh Med Res Counc Bull. 1995 Aug;21(2):64-72.PMID: 8815864 [PubMed - indexed for MEDLINE]Related articles

    7.

    LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.

    Jenkins AJ, Klein RL, Chassereau CN, Hermayer KL, Lopes-Virella MF.

    Diabetes. 1996 Jun;45(6):762-7.PMID: 8635650 [PubMed - indexed for MEDLINE]Related articles

    8.

    Metabolic heterogeneity in impaired glucose tolerance.

    Walker M, Berrish TS, Stewart MW, Humphriss DB, Barriocanal L, Alberti KG.

    Metabolism. 1997 Aug;46(8):914-7.PMID: 9258274 [PubMed - indexed for MEDLINE]Related articles

    9.

    Baseline diene conjugation in LDL lipids from newly diagnosed type 2 diabetic patients.

    Gavella M, Lipovac V, Car A, Vucic M.

    Diabetes Metab. 2002 Nov;28(5):391-6.PMID: 12461476 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease.

    Lautamäki R, Rönnemaa T, Huupponen R, Lehtimäki T, Iozzo P, Airaksinen KE, Knuuti J, Nuutila P.

    Metabolism. 2007 Jul;56(7):881-6.PMID: 17570246 [PubMed - indexed for MEDLINE]Related articles

    12.

    Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance.

    Yanagi K, Yamashita S, Kihara S, Nakamura T, Nozaki S, Nagai Y, Funahashi T, Kameda-Takemura K, Ueyama Y, Jiao S, Kubo M, Tokunaga K, Matsuzawa Y.

    Atherosclerosis. 1997 Jul 11;132(1):43-51.PMID: 9247358 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Significance of triglycerides for other metabolic parameters in the familial metabolic syndrome]

    Metzler W, Fücker K, Schwanebeck U, Hanefeld M, Julius U, Kindel B, Fischer S.

    Dtsch Med Wochenschr. 2003 Sep 19;128(38):1941-6. German. PMID: 14502445 [PubMed - indexed for MEDLINE]Related articles

    14.

    Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity.

    Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F, Hong J, Gu Y, Li X, Ning G, Chen M.

    Diabetes Res Clin Pract. 2006 Jun;72(3):244-50. Epub 2005 Dec 27.PMID: 16377022 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antibodies to oxidized low-density lipoprotein in patients following coronary artery revascularization.

    Miller ER 3rd, Erlinger TP, Blumenthal RS, Margolis S, Allen JK.

    Coron Artery Dis. 2003 Apr;14(2):163-9.PMID: 12655280 [PubMed - indexed for MEDLINE]Related articles

    16.

    Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.

    Marita AR, Sarkar JA, Rane S.

    Mol Cell Biochem. 2005 Jul;275(1-2):143-51.PMID: 16335794 [PubMed - indexed for MEDLINE]Related articles

    17.

    Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles.

    Tanaga K, Bujo H, Inoue M, Mikami K, Kotani K, Takahashi K, Kanno T, Saito Y.

    Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):662-6.PMID: 11950707 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.

    Lopes-Virella MF, Virella G, Orchard TJ, Koskinen S, Evans RW, Becker DJ, Forrest KY.

    Clin Immunol. 1999 Feb;90(2):165-72.PMID: 10080827 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition.

    Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Connelly PW, Zinman B.

    Diabetes Care. 2001 Jul;24(7):1240-7. Erratum in: Diabetes Care 2001 Oct;24(10):1851. PMID: 11423509 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data